These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 27751515)

  • 1. [Topical capsaicin cream in the treatment for cannabinoid hyperemesis syndrome].
    Román F; Llorens P; Burillo-Putze G
    Med Clin (Barc); 2016 Dec; 147(11):517-518. PubMed ID: 27751515
    [No Abstract]   [Full Text] [Related]  

  • 2. Resolution of cannabis hyperemesis syndrome with topical capsaicin in the emergency department: a case series.
    Dezieck L; Hafez Z; Conicella A; Blohm E; O'Connor MJ; Schwarz ES; Mullins ME
    Clin Toxicol (Phila); 2017 Sep; 55(8):908-913. PubMed ID: 28494183
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy of topical capsaicin for the treatment of cannabinoid hyperemesis syndrome: A retrospective cohort study.
    Yusuf HM; Geier C; Staidle A; Montoy JCC
    Am J Emerg Med; 2021 May; 43():142-148. PubMed ID: 33561623
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Capsaicin topical in emergency department treatment of cannabinoid hyperemesis syndrome.
    Waterson Duncan R; Maguire M
    Am J Emerg Med; 2017 Dec; 35(12):1977-1978. PubMed ID: 28712644
    [No Abstract]   [Full Text] [Related]  

  • 5. Capsaicin Cream for Treatment of Cannabinoid Hyperemesis Syndrome in Adolescents: A Case Series.
    Graham J; Barberio M; Wang GS
    Pediatrics; 2017 Dec; 140(6):. PubMed ID: 29122973
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Topical capsaicin for the treatment of cannabinoid hyperemesis syndrome, a systematic review and meta-analysis.
    Pourmand A; Esmailian G; Mazer-Amirshahi M; Lee-Park O; Tran QK
    Am J Emerg Med; 2021 May; 43():35-40. PubMed ID: 33493995
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy and safety of topical capsaicin for cannabinoid hyperemesis syndrome in the emergency department.
    Wagner S; Hoppe J; Zuckerman M; Schwarz K; McLaughlin J
    Clin Toxicol (Phila); 2020 Jun; 58(6):471-475. PubMed ID: 31482758
    [No Abstract]   [Full Text] [Related]  

  • 8. Efficacy of topical capsaicin for cannabinoid hyperemesis syndrome in a pediatric and adult emergency department.
    Kum V; Bell A; Fang W; VanWert E
    Am J Emerg Med; 2021 Nov; 49():343-351. PubMed ID: 34242945
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cannabinoid Hyperemesis Syndrome Secondary to Delta-8 THC Use.
    Rosenthal J; Howell M; Earl V; Malik M
    Am J Med; 2021 Dec; 134(12):e582-e583. PubMed ID: 34343506
    [No Abstract]   [Full Text] [Related]  

  • 10. Caution with topical capsaicin.
    Akel R; Cohen CE; Fuller C
    Clin Exp Dermatol; 2020 Aug; 45(6):739. PubMed ID: 32215935
    [No Abstract]   [Full Text] [Related]  

  • 11. SAEM GRACE: Dopamine antagonists and topical capsaicin for cannabis hyperemesis syndrome in the emergency department: A systematic review of direct evidence.
    Sabbineni M; Scott W; Punia K; Manuja K; Singh A; Campbell K; MacKillop J; Balodis I
    Acad Emerg Med; 2024 May; 31(5):493-503. PubMed ID: 37391387
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Management of Cannabinoid Hyperemesis Syndrome: Focus on Capsaicin.
    Stumpf JL; Williams LD
    J Pharm Pract; 2021 Oct; 34(5):786-793. PubMed ID: 32613883
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Is there scientific evidence for the use of topical capsaicin in osteoarthritis pain?].
    Alcántara Montero A; Sánchez Carnerero CI
    Semergen; 2017; 43(1):74-75. PubMed ID: 26924684
    [No Abstract]   [Full Text] [Related]  

  • 14. Short-term efficacy of topical capsaicin therapy in severely affected fibromyalgia patients.
    Casanueva B; Rodero B; Quintial C; Llorca J; González-Gay MA
    Rheumatol Int; 2013 Oct; 33(10):2665-70. PubMed ID: 22842953
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Pilot Trial of Topical Capsaicin Cream for Treatment of Cannabinoid Hyperemesis Syndrome.
    Dean DJ; Sabagha N; Rose K; Weiss A; France J; Asmar T; Rammal JA; Beyer M; Bussa R; Ross J; Chaudhry K; Smoot T; Wilson K; Miller J
    Acad Emerg Med; 2020 Nov; 27(11):1166-1172. PubMed ID: 32569429
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High concentration capsaicin for treatment of peripheral neuropathic pain: effect on somatosensory symptoms and identification of treatment responders.
    Höper J; Helfert S; Heskamp ML; Maihöfner CG; Baron R
    Curr Med Res Opin; 2014 Apr; 30(4):565-74. PubMed ID: 24286590
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Capsaicin. Neuropathic pain: playing with fire...
    Prescrire Int; 2010 Aug; 19(108):153-5. PubMed ID: 20939441
    [TBL] [Abstract][Full Text] [Related]  

  • 18. NGX-4010, a high-concentration capsaicin patch, for the treatment of postherpetic neuralgia: a randomized, double-blind, controlled study with an open-label extension.
    Backonja MM; Malan TP; Vanhove GF; Tobias JK;
    Pain Med; 2010 Apr; 11(4):600-8. PubMed ID: 20113411
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Different therapeutic strategies for burning mouth syndrome: preliminary data.
    Marino R; Torretta S; Capaccio P; Pignataro L; Spadari F
    J Oral Pathol Med; 2010 Sep; 39(8):611-6. PubMed ID: 20701667
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Topical agents in the treatment of rheumatic pain.
    Moore RA; Derry S; McQuay HJ
    Rheum Dis Clin North Am; 2008 May; 34(2):415-32. PubMed ID: 18638684
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.